结直肠癌导致的肝转移:ESSO-EAHPBA-UEMS联合核心课程合作
Lucia Carrion-Alvarez1, Florian Primavesi2, Kjetil Søreide3
1HPB Unit, General Surgery Department, Fuenlabrada University Hospital, Madrid, Spain.
概括
本文提供了关于结直肠肝转移 (CRLM) 管理的全面指南,解决了手术瘤学培训的差距. 它为诊断和多学科治疗提供了一个结构化的参考,帮助外科医生准备参加董事会考试.
科学领域:
- 手术瘤学手术瘤学
- 肝胆道手术 肝胆道手术
- 胃肠病学 胃肠病学
背景情况:
- 结肠直肠肝转移 (CRLM) 是欧洲肝脏手术的主要原因.
- 现有的欧洲外科瘤学会 (ESSO) 资源涵盖其他癌症,但缺乏具体的CRLM指导.
- 需要为外科瘤学候选人提供标准化的CRLM知识和培训.
研究的目的:
- 在外科瘤学中弥合结直肠肝转移 (CRLM) 的教育差距.
- 提供涵盖CRLM流行病学,分期,遗传学,诊断和治疗的结构化参考资料.
- 为了支持准备参加欧洲外科资格委员会 (EBSQ) 考试的外科医生.
主要方法:
- 使用PubMed进行结构化的文献综述.
- 优先考虑最近 (2020年1月至2025年1月) 的国际管理准则.
- 包括多中心研究,系统审查和元分析.
主要成果:
- 确定CRLM的当前 (国际) 管理准则.
- 综合CRLM的流行病学,诊断和遗传数据.
- 多学科治疗策略的概要,包括全身,手术,干预和息护理.
结论:
- 这篇文章为肝胆道外科医生和外科瘤学家提供了关于CRLM的重要,结构化的资源.
- 它与ESSO核心课程保持一致,增强子专业培训.
- 促进欧洲各地对CRLM的标准化教育和管理.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Chronic Pancreatitis II: Collaborative Care
56
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
56
Inflammatory Bowel Disease I: Ulcerative Colitis
112
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
112


